Predictors of Antimicrobial Resistance in the Respiratory Intensive Care Unit of Alexandria Main University Hospital

December 24, 2024 updated by: Mohamed Sabry
The goal of this clinical trial is to identify the predictors of antibiotic resistance whether clinical or laboratory or radiological or all

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The goal of this clinical trial is to identify the predictors of antibiotic resistance like the history of previous antibiotic ,the antibiogram of the centre , comorbidities,..etc to decide the suitable antibiotic

Study Type

Observational

Enrollment (Actual)

50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Egypt
    • Azarita
      • Alexandria, Azarita, Egypt, 11511
        • Chest Department -Faculty of Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

The current study aims to identify the predictors of antibiotic resistance in the respiratory intensive care unit of Alexandria main university hospital

Description

Inclusion Criteria:

  • Adult patient admitted to the respiratory ICU due to bacterial infection.

    • Recent antibiotic intake in the past three months.
    • Intercostal tube insertion for empyema.
    • Shocked patients with inserted central venous catheter.
    • Intubated or tracheostomized patients.
    • Patients with grade two to four bed sores.

Exclusion Criteria:

  • . Inability to provide written informed consent for the study.

    • Non sterile sample collection technique.
    • Inability to provide antibiogram.
    • Isolated patients due to suspected tuberculosis

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
only one group of patients
to identify the predictors of antibiotic resistance using rates of resistance,comprehensive data of each patient chest X ray,CT,ultrasound
Radiation: chest x ray
chest X ray identify severity of pneumonia
Other Names:
  • antibiogram
Drug: Tigecycline (Tygacil)
selective antibiogram

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
antibiogram
Time Frame: 3 months
resistance rates in antibiograms
3 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
resistance rates in the antibiogram
Time Frame: 3 months
culture and different antibiotic senstivity
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Mohamed Sabry

Investigators

  • Principal Investigator: mohamed sabry eltarhony, lecturer, Alexandria University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2024

Primary Completion (Actual)

December 11, 2024

Study Completion (Actual)

December 12, 2024

Study Registration Dates

First Submitted

December 20, 2024

First Submitted That Met QC Criteria

December 24, 2024

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

December 24, 2024

Last Verified

December 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • AMR-AMUH

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

because the facility, where i do my work, refuse to share any project untill it is fully published

Study Data/Documents

  1. Study Protocol
    Information identifier: msabry776@yahoo.com
    Information comments: very good

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

Yes

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe